Dr. Trevor Resnick, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $263,027 | 142 | 60.6% |
| Consulting Fee | $81,128 | 43 | 18.7% |
| Travel and Lodging | $44,568 | 194 | 10.3% |
| Honoraria | $26,850 | 19 | 6.2% |
| Food and Beverage | $18,476 | 624 | 4.3% |
| Education | $27.36 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $175,167 | 204 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $68,092 | 133 | $0 (2022) |
| Mallinckrodt Enterprises LLC | $57,130 | 58 | $0 (2019) |
| UCB, Inc. | $54,134 | 148 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $17,772 | 157 | $0 (2023) |
| Lundbeck LLC | $16,409 | 35 | $0 (2018) |
| Mallinckrodt Hospital Products Inc. | $11,508 | 6 | $0 (2020) |
| Catalyst Pharmaceuticals, Inc. | $8,296 | 7 | $0 (2023) |
| SK Life Science, Inc. | $5,281 | 25 | $0 (2023) |
| UCB SA | $4,959 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,565 | 27 | UCB, Inc. ($5,847) |
| 2023 | $16,379 | 137 | Catalyst Pharmaceuticals, Inc. ($8,296) |
| 2022 | $20,759 | 164 | UCB, Inc. ($8,327) |
| 2021 | $15,181 | 84 | Eisai Inc. ($7,389) |
| 2020 | $53,280 | 70 | Eisai Inc. ($23,688) |
| 2019 | $110,271 | 196 | EISAI INC. ($61,050) |
| 2018 | $160,064 | 235 | Eisai Inc. ($57,813) |
| 2017 | $50,578 | 111 | Eisai Inc. ($23,406) |
All Payment Transactions
1,024 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $144.54 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Neurology | ||||||
| 12/07/2024 | AQUESTIVE THERAPEUTICS, INC. | LIBERVANT (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Neurology | ||||||
| 11/12/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Neurology | ||||||
| 11/12/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $6.70 | General |
| Category: Neurology | ||||||
| 11/05/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: NEUROLOGY | ||||||
| 11/04/2024 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Neurology | ||||||
| 11/04/2024 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | Cash or cash equivalent | $46.90 | General |
| Category: Neurology | ||||||
| 11/04/2024 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | Cash or cash equivalent | $14.98 | General |
| Category: Neurology | ||||||
| 10/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $124.55 | General |
| Category: Neurology | ||||||
| 10/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neurology | ||||||
| 10/16/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $39.07 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2024 | Otter Pharmaceuticals, LLC | SYMPAZAN (Drug) | Consulting Fee | Cash or cash equivalent | $1,338.00 | General |
| Category: Neurology | ||||||
| 09/26/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: NEUROLOGY | ||||||
| 09/05/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $122.33 | General |
| Category: Neurology | ||||||
| 09/03/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: NEUROLOGY | ||||||
| 08/29/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Neurology | ||||||
| 08/28/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 08/13/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: NEUROLOGY | ||||||
| 02/14/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 11 | 14 | $7,476 | $507.86 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 14 | $7,476 | $507.86 | 6.8% |
About Dr. Trevor Resnick, MD
Dr. Trevor Resnick, MD is a Neurology with Special Qualifications in Child Neurology healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780641381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Trevor Resnick, MD has received a total of $434,077 in payments from pharmaceutical and medical device companies, with $7,565 received in 2024. These payments were reported across 1,024 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($263,027).
As a Medicare-enrolled provider, Resnick has provided services to 11 Medicare beneficiaries, totaling 14 services with total Medicare billing of $507.86. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Practice Information
- Specialty Neurology with Special Qualifications in Child Neurology
- Other Specialties Neurology
- Location Miami, FL
- Active Since 04/27/2006
- Last Updated 07/14/2022
- Taxonomy Code 2084N0402X
- Entity Type Individual
- NPI Number 1780641381
Products in Payments
- Fycompa (Drug) $169,739
- ACTHAR (Biological) $68,638
- APTIOM (Drug) $62,617
- Vimpat (Drug) $31,854
- Briviact (Drug) $22,113
- OXTELLAR XR (Drug) $17,260
- ONFI (Drug) $16,409
- Banzel (Drug) $8,428
- FYCOMPA (Drug) $8,296
- Aptiom (Drug) $5,776
- Nayzilam (Drug) $3,956
- Cenobamate (Drug) $3,868
- SYMPAZAN (Drug) $2,682
- EPIDIOLEX (Drug) $1,357
- XCOPRI (Drug) $1,000
- LIBERVANT (Drug) $924.31
- Eprontia (Drug) $923.34
- Fintepla (Drug) $703.57
- VNS Therapy (Device) $694.15
- VALTOCO (Drug) $650.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology with Special Qualifications in Child Neurology Doctors in Miami
Dr. Migvis Monduy, M.d, M.D
Neurology with Special Qualifications in Child Neurology — Payments: $194,813
Elza Vasconcellos, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $159,298
Dr. Matt Lallas, M.d, M.D
Neurology with Special Qualifications in Child Neurology — Payments: $103,938
Walter Bradley
Neurology with Special Qualifications in Child Neurology — Payments: $79,256
Roberto Lopez-Alberola
Neurology with Special Qualifications in Child Neurology — Payments: $27,260
Paula Schleifer, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $23,853